Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
cloudsquid | $1,000,000 | (Nov 5, 2024)
Anavo Therapeutics BV
Netherlands
- Leiden, South Holland
- 04/05/2023
- Seed
- $9,406,482
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.
We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications.
Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures.
- Industry Biotechnology Research
- Website https://www.anavotx.com/
- LinkedIn https://www.linkedin.com/company/anavo-therapeutics-bv/
Related People
Birgit ZechFounder
Germany -
ND
• 20 years working experience in Biotech, 15+ years in Business Development
• In depth knowledge of the pharmaceutical and biotech industry
• Excellent track record in deal making and fundraising
• Strong network to leading Pharma and Biotech companies, significant partnering experience in EP, US and JP
• Over 5 years experience in IP management
• Strong background in chemistry (small molecules, kinase inhibitors, protein modeling) and biology (antibodies, next generation scaffolds)
Cintoo | $40,246,701 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Plato | $6,500,000 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Birl | $647,878 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
OpenOrigins | $4,500,000 | (Nov 1, 2024)
Persana AI | $2,300,000 | (Nov 1, 2024)
Definition Health | $7,412,756 | (Nov 1, 2024)